- All sections
- C - Chemistry; metallurgy
- C07H - Sugars; derivatives thereof; nucleosides; nucleotides; nucleic acids
- C07H 21/02 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
Patent holdings for IPC class C07H 21/02
Total number of patents in this class: 6081
10-year publication summary
444
|
426
|
360
|
379
|
319
|
315
|
218
|
203
|
185
|
44
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Alnylam Pharmaceuticals, Inc. | 1066 |
195 |
Ionis Pharmaceuticals, Inc. | 776 |
145 |
The Regents of the University of California | 18943 |
110 |
President and Fellows of Harvard College | 5792 |
80 |
Agilent Technologies, Inc. | 2744 |
64 |
University of Massachusetts | 2130 |
57 |
The Trustees of the University of Pennsylvania | 4122 |
51 |
Modernatx, Inc. | 1181 |
48 |
The Johns Hopkins University | 5377 |
46 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
42 |
Life Technologies Corporation | 3068 |
42 |
Pacific Biosciences of California, Inc. | 738 |
41 |
Arrowhead Pharmaceuticals, Inc. | 216 |
40 |
City of Hope | 943 |
40 |
The General Hospital Corporation | 4517 |
36 |
California Institute of Technology | 3884 |
32 |
The Board of Regents of the University of Texas System | 2043 |
32 |
Translate bio, Inc. | 394 |
32 |
Board of Regents, The University of Texas System | 5370 |
31 |
Dicerna Pharmaceuticals, Inc. | 278 |
31 |
Other owners | 4886 |